The Therapeutic Potential of Novel Carnosine Formulations: Perspectives for Drug Development
Carnosine (beta-alanyl-L-histidine) is an endogenous dipeptide synthesized via the activity of the ATP-dependent enzyme carnosine synthetase 1 and can be found at a very high concentration in tissues with a high metabolic rate, including muscles (up to 20 mM) and brain (up to 5 mM). Because of its w...
Saved in:
Main Authors: | Angela Bonaccorso (Author), Anna Privitera (Author), Margherita Grasso (Author), Sonya Salamone (Author), Claudia Carbone (Author), Rosario Pignatello (Author), Teresa Musumeci (Author), Filippo Caraci (Author), Giuseppe Caruso (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms
by: Giuseppe Caruso, et al.
Published: (2023) -
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
by: Elide Zingale, et al.
Published: (2022) -
Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
by: Margherita Grasso, et al.
Published: (2021) -
Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages
by: Giuseppe Caruso, et al.
Published: (2019) -
Microfluidic/HPLC combination to study carnosine protective activity on challenged human microglia: Focus on oxidative stress and energy metabolism
by: Anna Privitera, et al.
Published: (2023)